Topotecan-d6 – 1 mg

Brand:
Cayman
CAS:
1044904-10-0
Storage:
-20
UN-No:
Non-Hazardous - /

Topotecan-d6 is intended for use as an internal standard for the quantification of topotecan (Item No. 14129) by GC- or LC-MS. Topotecan is an inhibitor of DNA topoisomerase I and a derivative of the DNA topoisomerase I inhibitor camptothecin (Item No. 11694).{21114,21115,22689} Topotecan inhibits DNA topoisomerase I in human MCF-7 breast and DU145 prostate cancer cells with IC50 values of 13 and 2 nM, respectively, in a cell-based luciferase reporter assay.{42991} Topotecan induces cytotoxicity and DNA damage in HT-29 human colon adenocarcinoma cells (IC50s = 33 and 280 nM, respectively).{21114} Formulations containing topotecan have been used in the treatment of small-cell lung cancer.  

 

Available on backorder

SKU: 29082 - 1 mg Category:

Description

An internal standard for the quantification of topotecan by GC- or LC-MS


Formal name: (4S)-10-[[di(methyl-d3)amino]methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

Synonyms: 

Molecular weight: 427.5

CAS: 1044904-10-0

Purity: ≥99% deuterated forms (d1-d6)

Formulation: A solid